Superworth

Black Hawk Acquisition BKHA

Biotechnology, Healthcare
$4.70
−0.42%
Market cap
$19.5M
PE
n/m
one or more of the four quarters through 2026-08-31 missing
Forward PE
n/m
not a meaningful number
Price to sales
n/m
not a meaningful number
EV/EBIT
n/m
a loss over the last year
Revenue, 12 months
n/m
not a meaningful number
Net margin
n/m
not a meaningful number
Free cash flow yield
n/m
not a meaningful number

Charts

Financials

Income statement for BKHA, by quarter
Income statementQ1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
SG&A$30.7K$335.3K$54.9K$71.3K$78.8K+157%$217.6K−35%$311.3K+467%$187.9K+164%$24.2K−69%$79.2K−64%$108.2K−65%
−$30.7K−$359.2K−$84.9K−$101.3K−$108.8K+254%−$247.6K−31%−$341.3K+302%−$217.9K+115%−$54.2K−50%−$109.2K−56%−$138.2K−60%
Interest expensen/an/an/an/an/an/an/an/a$19.4K$24.4K$33.2K
Net income−$30.7K$310.9K$883.8K$751.7K$658.4K$520.5K+67%$154.4K−83%−$3.8K$139.8K−79%$88.9K−83%$1.1M+596%
n/an/an/an/a$0.07$0.06$0.03n/a$0.03−57%$0.02−67%$0.26+767%
n/an/an/an/a6.9M6.9M4.1Mn/a2.1M−69%2.1M−69%2.1M−48%

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Healthcare nearest Black Hawk Acquisition's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
BKHABlack Hawk Acquisition$19.5Mn/mn/an/mn/mn/m
NEPHNephros$35.2M20.3×28.3×1.7×+24%8.4%
ATNMActinium Pharmaceuticals$45M4.0×3.3×n/mn/mn/m
APTAlpha Pro Tech$56.3M13.5×14.8×0.9×+6%6.8%
SPROSpero Therapeutics$60.6M9.5×9.5×1.3×−3%15.7%
LFVNLifevantage$73.5M14.7×19.4×0.4×−20%2.8%
ICCCImmucell$95.9M132×44.1×3.1×+8%2.6%
KEQUKewaunee Scientific$96.7M12.1×13.6×0.3×+5%3.0%
PDEXPro DEX$184.5M15.9×16.5×2.3×+13%15.1%
Peer median$67M14.1×15.7×1.3×+6%6.8%

More on Black Hawk Acquisition

Each number over time

Its groups

About

Industry
Biotechnology
Sector
Healthcare

Valuation data, not investment advice. Prices as of .